{"id":12837,"date":"2022-10-16T13:36:32","date_gmt":"2022-10-16T11:36:32","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12837"},"modified":"2026-03-03T10:49:59","modified_gmt":"2026-03-03T09:49:59","slug":"position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/","title":{"rendered":"Position commune sur la r\u00e9vision de la prise en charge dans des cas particuliers (OAMal, art. 71a \u00e0 d)"},"content":{"rendered":"\n<p>Les 21 organisations signataires rejettent la r\u00e9vision propos\u00e9e par le Conseil f\u00e9d\u00e9ral et offrent en m\u00eame temps leur aide pour l\u2019\u00e9laboration commune d\u2019un nouveau projet.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les 21 organisations signataires rejettent la r\u00e9vision propos\u00e9e par le Conseil f\u00e9d\u00e9ral et offrent en m\u00eame temps leur aide pour l\u2019\u00e9laboration commune d\u2019un nouveau projet.<\/p>\n","protected":false},"author":1,"featured_media":2545,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[54],"class_list":["post-12837","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-medien-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Position commune sur la r\u00e9vision de la prise en charge dans des cas particuliers (OAMal, art. 71a \u00e0 d) - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Position commune sur la r\u00e9vision de la prise en charge dans des cas particuliers (OAMal, art. 71a \u00e0 d)\" \/>\n<meta property=\"og:description\" content=\"Les 21 organisations signataires rejettent la r\u00e9vision propos\u00e9e par le Conseil f\u00e9d\u00e9ral et offrent en m\u00eame temps leur aide pour l\u2019\u00e9laboration commune d\u2019un nouveau projet.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-16T11:36:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T09:49:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/10\/kvv_brief_F.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1445\" \/>\n\t<meta property=\"og:image:height\" content=\"722\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Position commune sur la r\u00e9vision de la prise en charge dans des cas particuliers (OAMal, art. 71a \u00e0 d)\",\"datePublished\":\"2022-10-16T11:36:32+00:00\",\"dateModified\":\"2026-03-03T09:49:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/\"},\"wordCount\":50,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/10\/kvv_brief_F.png\",\"keywords\":[\"M\u00e9dias\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2022\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/\",\"url\":\"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/\",\"name\":\"Position commune sur la r\u00e9vision de la prise en charge dans des cas particuliers (OAMal, art. 71a \u00e0 d) - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/10\/kvv_brief_F.png\",\"datePublished\":\"2022-10-16T11:36:32+00:00\",\"dateModified\":\"2026-03-03T09:49:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/10\/kvv_brief_F.png\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/10\/kvv_brief_F.png\",\"width\":1445,\"height\":722},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Position commune sur la r\u00e9vision de la prise en charge dans des cas particuliers (OAMal, art. 71a \u00e0 d)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Position commune sur la r\u00e9vision de la prise en charge dans des cas particuliers (OAMal, art. 71a \u00e0 d) - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/","og_locale":"fr_FR","og_type":"article","og_title":"Position commune sur la r\u00e9vision de la prise en charge dans des cas particuliers (OAMal, art. 71a \u00e0 d)","og_description":"Les 21 organisations signataires rejettent la r\u00e9vision propos\u00e9e par le Conseil f\u00e9d\u00e9ral et offrent en m\u00eame temps leur aide pour l\u2019\u00e9laboration commune d\u2019un nouveau projet.","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/","og_site_name":"Interpharma","article_published_time":"2022-10-16T11:36:32+00:00","article_modified_time":"2026-03-03T09:49:59+00:00","og_image":[{"width":1445,"height":722,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/10\/kvv_brief_F.png","type":"image\/png"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"berta_admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Position commune sur la r\u00e9vision de la prise en charge dans des cas particuliers (OAMal, art. 71a \u00e0 d)","datePublished":"2022-10-16T11:36:32+00:00","dateModified":"2026-03-03T09:49:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/"},"wordCount":50,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/10\/kvv_brief_F.png","keywords":["M\u00e9dias"],"inLanguage":"fr-FR","copyrightYear":"2022","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/","name":"Position commune sur la r\u00e9vision de la prise en charge dans des cas particuliers (OAMal, art. 71a \u00e0 d) - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/10\/kvv_brief_F.png","datePublished":"2022-10-16T11:36:32+00:00","dateModified":"2026-03-03T09:49:59+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/10\/kvv_brief_F.png","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/10\/kvv_brief_F.png","width":1445,"height":722},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/position-commune-sur-la-revision-de-la-prise-en-charge-dans-des-cas-particuliers-oamal-art-71a-a-d\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Position commune sur la r\u00e9vision de la prise en charge dans des cas particuliers (OAMal, art. 71a \u00e0 d)"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=12837"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12837\/revisions"}],"predecessor-version":[{"id":12838,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12837\/revisions\/12838"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/2545"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=12837"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=12837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}